As the changes in synaptic circuits contribute to long-term neuropsychological changes and cognitive deficits observed in humans following brain injury, the regulation of ephrin-B1/EphB receptor signaling may provide new therapeutic opportunities to moderate synaptic connectivity and aid functional recovery after TBI. The gene discussed is EFNB1; the disease is Cognitive impairment.